About this trial
Full quantitative perfusion of the myocardial wall using MRI is a difficult method for several reasons. First the perfusion algorithm is mostly only relatively available, usually available algorithms /e.g. ISP/ shows not precise results according to our measurements, secondly based on signal physics and nature of MRI scans is not easy to get absolute numbers and specific new algorithms must be developed and tested. Such a tool is not only needed for some special cohort of patients, like 3-vessel disease, coronary artery disease or diffuse coronary artery involvement in coronary vasculopathy in patients after heart transplantation. Fully quantitative perfusion analysis is highly needed for nearly all cardiac patients to better characterise the health and status of the myocardium.
Eligibility criteria
Qualifiers
Signed informed consent
Patients indicated for a non-invasive test for ischemic heart disease/chronic coronary syndrome
Patients with intermittent chest pain and low to moderate probability of chronic coronary syndrome
Disqualifiers
Presence of relative or absolute contraindications to stress testing, including acute coronary syndrome, life-threatening arrhythmias, severe chronic obstructive pulmonary disease (COPD), or second- or third-degree atrioventricular (AV) block.
Contraindications to MRI, such as severe claustrophobia, presence of ferromagnetic material or implants, or severe renal impairment.
Trial design
Treatments tested in this trial
- Magnetic Resonance Imaging with Contrast
Treatment groups
Sponsors and collaborators
St. Anne's University Hospital Brno, Czech Republic
Lead sponsor
Philips Medical Systems
Collaborator